A new bone-inducing biodegradable porous β-tricalcium phosphate

被引:59
作者
Matsushita, N
Terai, H
Okada, T
Nozaki, K
Inoue, H
Miyamoto, S
Takaoka, K
机构
[1] Osaka City Univ, Sch Med, Dept Orthopaed Surg, Abeno Ku, Osaka 5458585, Japan
[2] Taki Chem Co Ltd, Res Dept, R&D Div, Kakogawa, Hyogo 6750125, Japan
[3] Yamanouchi Pharmaceut Co Ltd, Appl Pharmacol Labs, Inst Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan
[4] Olympus Co Ltd, Hachioji, Tokyo 1928512, Japan
关键词
BMP; beta-TCP; synthetic delivery system; osteoinductive; biodegradable;
D O I
10.1002/jbm.a.30102
中图分类号
R318 [生物医学工程];
学科分类号
0831 [生物医学工程];
摘要
A new type of degradable biomaterial with bone-inducing capacity was made by combining porous beta-tricalcium phosphate (beta-TCP) with a delivery system for recombinant human bone morphogenetic protein-2 (rhBMP-2). The BMP delivery system consisted of a block copolymer composed of poly-D,L-lactic acid with random insertion of p-dioxanone and polyethylene glycol (PLA-DX-PEG), a known biocompatible and biodegradable material. The efficacy of this biomaterial in terms of its bone-inducing capacity was examined by ectopic bone formation in the dorsal muscles of the mouse. In the beta-TCP implants coated with the PLA-DX-PEG polymer containing more than 0.0025% (w/w) of rhBMP-2, new ectopic bone tissues with marrow were consistently found on the surface of implants. The radio-graphic density of beta-TCP was diminished in a time-dependent manner. On histological examination, numerous multinucleated osteoclasts with positive tartrate-resistant acid-phosphatase (TRAP) staining were noted on the surface of the beta-TCP. These experimental results indicate that beta-TCP implants coated with synthetic rhBMP-2 delivery system might provide effective artificial bone-graft substitutes with osteoinductive capacity and biodegradable properties. In addition, this type of biomaterial may require less rhBMP-2 to induce significant new bone mass. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:450 / 458
页数:9
相关论文
共 19 条
[1]
Alam MI, 2001, J BIOMED MATER RES, V54, P129, DOI 10.1002/1097-4636(200101)54:1<129::AID-JBM16>3.3.CO
[2]
2-4
[3]
Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
[4]
Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673
[5]
ENHANCEMENT OF FRACTURE-HEALING [J].
EINHORN, TA .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1995, 77A (06) :940-956
[6]
Jingushi Seiya, 2002, J Orthop Sci, V7, P490, DOI 10.1007/s007760200085
[7]
Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects [J].
Laffargue, P ;
Hildebrand, HF ;
Rtaimate, M ;
Frayssinet, P ;
Amoureux, JP ;
Marchandise, X .
BONE, 1999, 25 (02) :55S-58S
[8]
Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier [J].
Murakami, N ;
Saito, N ;
Takahashi, J ;
Ota, H ;
Horiuchi, H ;
Nawata, M ;
Okada, T ;
Nozaki, K ;
Takaoka, K .
BIOMATERIALS, 2003, 24 (13) :2153-2159
[9]
Repair of segmental defects in rabbit humeri with titanium fiber mesh cylinders containing recombinant human bone morphogenetic protein-2 (rhBMP-2) and a synthetic polymer [J].
Murakami, N ;
Saito, N ;
Horiuchi, H ;
Okada, T ;
Nozaki, K ;
Takaoka, K .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 62 (02) :169-174
[10]
Histological examination of β-tricalcium phosphate graft in human femur [J].
Ogose, A ;
Hotta, T ;
Hatano, H ;
Kawashima, H ;
Tokunaga, K ;
Endo, N ;
Umezu, H .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 63 (05) :601-604